
Praxis Precision Medicines, Inc.: shareholders and insiders
Price
$300.43
November 20, 2026Market cap $8.4B
What Ploutos Investor adds for Praxis Precision Medicines
Part of Ploutos Investor, €9.99 a month
- The full history: 4 fiscal years, from 2022
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 22, 2025 to Nov 18, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$3.6M
1 person
From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan100%
- The rest0%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $3.6M by 1 person
- 2025: no buys, no sales
- 2026: no buys, sold $3.6M by 1 person
- Nov 13, 2026Megan SniecinskiChief Operating OfficerKind
- Nov 13, 2026Alex NemiroffGeneral Counsel and SecretaryKind
- Nov 13, 2026Timothy Edwin KellyChief Financial OfficerKind
- Nov 13, 2026Lauren MastrocolaPrincipal Accounting OfficerKind
- Jul 8, 2026Marcio SouzaChief Executive OfficerKind
- Jul 8, 2026Marcio SouzaChief Executive OfficerKind
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 24, 2026Jill DeSimoneDirectorKind10b5-1
- Jun 10, 2026Stuart A ArbuckleDirectorKind
- Jun 10, 2026Jeffrey ChodakewitzDirectorKind
- Jun 10, 2026William D YoungDirectorKind
- Jun 10, 2026Jill DeSimoneDirectorKind
- Jun 10, 2026Merit Ester CudkowiczDirectorKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | Megan SniecinskiChief Operating Officer | 21 | $278.91 | $5.9K | Form 4 | |
| Nov 13, 2026 | Alex NemiroffGeneral Counsel and Secretary | 49 | $278.91 | $13.7K | Form 4 | |
| Nov 13, 2026 | Timothy Edwin KellyChief Financial Officer | 3 | $278.91 | $837 | Form 4 | |
| Nov 13, 2026 | Lauren MastrocolaPrincipal Accounting Officer | 72 | $278.91 | $20.1K | Form 4 | |
| Jul 8, 2026 | Marcio SouzaChief Executive Officer | 20.5K | – | – | Form 4 | |
| Jul 8, 2026 | Marcio SouzaChief Executive Officer | 2,600 | – | – | Form 4 | |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 8,566 | $44.25 | $379.0K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 3,034 | $147.30 | $446.9K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 10 | $301.44 | $3.0K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 120 | $303.13 | $36.4K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 320 | $305.31 | $97.7K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 683 | $306.77 | $209.5K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 1,240 | $308.24 | $382.2K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 999 | $309.38 | $309.1K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 1,750 | $310.89 | $544.1K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 2,854 | $311.91 | $890.2K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 1,004 | $312.83 | $314.1K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 504 | $313.66 | $158.1K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 1,279 | $314.90 | $402.8K | Form 4 |
| Jun 24, 2026 | Jill DeSimoneDirector | 10b5-1 | 837 | $315.71 | $264.2K | Form 4 |
| Jun 10, 2026 | Stuart A ArbuckleDirector | 1,371 | – | – | Form 4 | |
| Jun 10, 2026 | Jeffrey ChodakewitzDirector | 1,371 | – | – | Form 4 | |
| Jun 10, 2026 | William D YoungDirector | 1,371 | – | – | Form 4 | |
| Jun 10, 2026 | Jill DeSimoneDirector | 1,371 | – | – | Form 4 | |
| Jun 10, 2026 | Merit Ester CudkowiczDirector | 1,371 | – | – | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade.
Insiders and their shares
Every buy and sale by PRAX's officers and directors from 2020 up to November 21, 2025, 6 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 1 more, back to 2020
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Janus Henderson Groupwith 1 more personShare of class12.3%
- FMRwith 1 more personShare of class9.20%
- Perceptive Advisors LLCwith 2 more personsShare of class7.20%
- Baker Bros. Advisors LPwith 3 more personsShare of class6.30%
- Orbis Investment Managementwith 1 more personShare of class5.50%
- Vanguard Capital ManagementShare of class5.09%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Janus Henderson Groupwith 1 more person | 12.3% | 2.76M | Nov 14, 20254 filings since May 14, 2025 | 13G/A | |
| FMRwith 1 more person | 9.20% | 2.57M | Nov 5, 20263 filings since Feb 5, 2026 | 13G/A | |
| Perceptive Advisors LLCwith 2 more persons | 7.20% | 2.00M | Feb 17, 20264 filings since Feb 14, 2025 | 13G/A | |
| Baker Bros. Advisors LPwith 3 more persons | 6.30% | 1.75M | May 15, 2026 | 13G | |
| Orbis Investment Managementwith 1 more person | 5.50% | 1.53M | Aug 14, 20263 filings since Feb 17, 2026 | 13G/A | |
| Vanguard Capital Management | 5.09% | 1.42M | Apr 30, 2026 | 13G |
Fell to 5% or less (9)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- Point72 Asset Management, L.P.0.20%May 15, 202613G/A
- The Vanguard Group0.00%Mar 27, 202613G/A
- Adage Capital Management, L.P.3.83%Feb 12, 202613G/A
- Cormorant Asset Management, LP4.00%Nov 14, 202513G/A
- T. Rowe Price Associates, Inc.4.80%Nov 14, 202513G/A
- Morgan Stanley2.90%Nov 7, 202513G/A
- Soleus Capital Master Fund, L.P.4.60%Aug 5, 202513G/A
- Venrock Healthcare Capital Partners III, L.P.4.90%May 15, 202513G/A
- Capital Research Global Investors4.20%May 13, 202513G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter+188%
- Millennium Mgmt (Englander)In the quarter+638%
- D.E. ShawIn the quarter+55%
- AQR CapitalIn the quarter-3.5%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 21.1K | +188% | $6.1M | 0.00% |
| Millennium Mgmt (Englander) | 7,339 | +638% | $2.1M | 0.00% |
| D.E. Shaw | 7,980 | +55% | $2.3M | 0.00% |
| AQR Capital | 56.4K | -3.5% | $16M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 14.1% of its shares outstanding were held short, -6.4% since the report before.
- Shares held short
- 3.92M
- 14.1%
- Since the report before4.19M on Sep 30, 2026
- -6.4%
- 7.4
- 529.1K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 80%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 2.76M
- Nov 15, 2023: Shares held short 3.46M
- Nov 30, 2023: Shares held short 198.7K
- Dec 15, 2023: Shares held short 235.5K
- Dec 29, 2023: Shares held short 371.0K
- Jan 12, 2024: Shares held short 486.7K
- Jan 31, 2024: Shares held short 564.0K
- Feb 15, 2024: Shares held short 348.9K
- Feb 29, 2024: Shares held short 414.8K
- Mar 15, 2024: Shares held short 409.3K
- Mar 28, 2024: Shares held short 431.4K
- Apr 15, 2024: Shares held short 763.9K
- Apr 30, 2024: Shares held short 824.4K
- May 15, 2024: Shares held short 844.9K
- May 31, 2024: Shares held short 702.2K
- Jun 14, 2024: Shares held short 865.3K
- Jun 28, 2024: Shares held short 1.41M
- Jul 15, 2024: Shares held short 1.59M
- Jul 31, 2024: Shares held short 1.89M
- Aug 15, 2024: Shares held short 1.86M
- Aug 30, 2024: Shares held short 1.94M
- Sep 13, 2024: Shares held short 1.90M
- Sep 30, 2024: Shares held short 1.80M
- Oct 15, 2024: Shares held short 1.72M
- Oct 31, 2024: Shares held short 1.72M
- Nov 15, 2024: Shares held short 1.53M
- Nov 29, 2024: Shares held short 1.47M
- Dec 13, 2024: Shares held short 1.53M
- Dec 31, 2024: Shares held short 1.90M
- Jan 15, 2025: Shares held short 2.04M
- Jan 31, 2025: Shares held short 2.62M
- Feb 14, 2025: Shares held short 2.67M
- Feb 28, 2025: Shares held short 1.82M
- Mar 14, 2025: Shares held short 2.06M
- Mar 31, 2025: Shares held short 1.99M
- Apr 15, 2025: Shares held short 1.85M
- Apr 30, 2025: Shares held short 1.77M
- May 15, 2025: Shares held short 1.88M
- May 30, 2025: Shares held short 1.80M
- Jun 13, 2025: Shares held short 1.74M
- Jun 30, 2025: Shares held short 1.78M
- Jul 15, 2025: Shares held short 1.94M
- Jul 31, 2025: Shares held short 2.12M
- Aug 15, 2025: Shares held short 2.33M
- Aug 29, 2025: Shares held short 2.36M
- Sep 15, 2025: Shares held short 2.38M
- Sep 30, 2025: Shares held short 2.64M
- Oct 15, 2025: Shares held short 2.61M
- Oct 31, 2025: Shares held short 3.06M
- Nov 14, 2025: Shares held short 3.61M
- Nov 28, 2025: Shares held short 3.55M
- Dec 15, 2025: Shares held short 3.67M
- Dec 31, 2025: Shares held short 3.76M
- Jan 15, 2026: Shares held short 3.75M
- Jan 30, 2026: Shares held short 3.86M
- Feb 13, 2026: Shares held short 3.80M
- Feb 27, 2026: Shares held short 3.79M
- Mar 13, 2026: Shares held short 3.74M
- Mar 31, 2026: Shares held short 3.95M
- Apr 15, 2026: Shares held short 3.78M
- Apr 30, 2026: Shares held short 3.78M
- May 15, 2026: Shares held short 3.71M
- May 29, 2026: Shares held short 3.65M
- Jun 15, 2026: Shares held short 3.57M
- Jun 30, 2026: Shares held short 3.99M
- Jul 15, 2026: Shares held short 3.76M
- Jul 31, 2026: Shares held short 3.66M
- Aug 14, 2026: Shares held short 3.71M
- Aug 31, 2026: Shares held short 3.74M
- Sep 15, 2026: Shares held short 3.80M
- Sep 30, 2026: Shares held short 4.19M
- Oct 15, 2026: Shares held short 3.92M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading50.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 50.5% of the shares in the reported trades were short sales, against 63.0% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 50.5%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 63.0%
- Change
- -12.5 pts
- Short sales a dayon average, of 250.8K shares
- 126.6K
- More than atof 3,666 US-listed companies, same days
- 50%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 28.3%
- Oct 15, 2026: Short sales 56.5%
- Oct 16, 2026: Short sales 71.4%
- Oct 19, 2026: Short sales 68.7%
- Oct 20, 2026: Short sales 73.6%
- Oct 21, 2026: Short sales 65.6%
- Oct 22, 2026: Short sales 72.3%
- Oct 23, 2026: Short sales 54.8%
- Oct 26, 2026: Short sales 84.8%
- Oct 27, 2026: Short sales 78.6%
- Oct 28, 2026: Short sales 72.7%
- Oct 29, 2026: Short sales 80.8%
- Oct 30, 2026: Short sales 58.6%
- Nov 2, 2026: Short sales 60.2%
- Nov 3, 2026: Short sales 73.2%
- Nov 4, 2026: Short sales 73.8%
- Nov 5, 2026: Short sales 62.7%
- Nov 6, 2026: Short sales 40.4%
- Nov 9, 2026: Short sales 42.4%
- Nov 10, 2026: Short sales 58.4%
- Nov 11, 2026: Short sales 58.3%
- Nov 12, 2026: Short sales 41.9%
- Nov 13, 2026: Short sales 52%
- Nov 16, 2026: Short sales 44.4%
- Nov 17, 2026: Short sales 42.7%
- Nov 18, 2026: Short sales 36%
- Nov 19, 2026: Short sales 57.9%
- Nov 20, 2026: Short sales 66.5%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Phillip GrossTenPercentOwnerDirectly–
- Marcio SouzaChief Executive OfficerDirectly56.5K
- Timothy Edwin KellyChief Financial OfficerDirectly31.2K
- Megan SniecinskiChief Operating OfficerDirectly28.7K
- Alex NemiroffGeneral Counsel and SecretaryDirectly26.1K
- Dean J MitchellDirectorDirectly18.6K
- Jill DeSimoneDirectorDirectly13.8K
- Lauren MastrocolaPrincipal Accounting OfficerDirectly13.6K
- William D YoungDirectorDirectly3,269
- Stuart A ArbuckleDirectorDirectly2,537
- Jeffrey B KindlerDirectorDirectly2,537
- Gregory NordenDirectorDirectly1,559
- Jeffrey ChodakewitzDirectorDirectly1,371
- Merit Ester CudkowiczDirectorDirectly1,371
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Phillip GrossTenPercentOwner | – | 2.08M | Oct 16, 2025 | Form 4 |
| Marcio SouzaChief Executive Officer | 56.5K | – | Jul 8, 2026 | Form 4 |
| Timothy Edwin KellyChief Financial Officer | 31.2K | – | Nov 13, 2026 | Form 4 |
| Megan SniecinskiChief Operating Officer | 28.7K | – | Nov 13, 2026 | Form 4 |
| Alex NemiroffGeneral Counsel and Secretary | 26.1K | – | Nov 13, 2026 | Form 4 |
| Dean J MitchellDirector | 18.6K | – | Jun 10, 2026 | Form 4 |
| Jill DeSimoneDirector | 13.8K | – | Jun 24, 2026 | Form 4 |
| Lauren MastrocolaPrincipal Accounting Officer | 13.6K | – | Nov 13, 2026 | Form 4 |
| William D YoungDirector | 3,269 | – | Jun 10, 2026 | Form 4 |
| Stuart A ArbuckleDirector | 2,537 | – | Jun 10, 2026 | Form 4 |
| Jeffrey B KindlerDirector | 2,537 | – | Jun 10, 2026 | Form 4 |
| Gregory NordenDirector | 1,559 | – | Jun 10, 2026 | Form 4 |
| Jeffrey ChodakewitzDirector | 1,371 | – | Jun 10, 2026 | Form 4 |
| Merit Ester CudkowiczDirector | 1,371 | – | Jun 10, 2026 | Form 4 |
A lower bound: it counts only the 14 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- XBIState Street(R) SPDR(R) S&P(R) Biotech ETFWeight in the fund1.29%
- LABUDirexion Daily S&P Biotech Bull 3X SharesWeight in the fund0.87%
- IBBiShares Biotechnology ETFWeight in the fund0.68%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.51%
- FESMFidelity Enhanced Small Cap Core ETFWeight in the fund0.28%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.28%
- IWMiShares Russell 2000 ETFWeight in the fund0.26%
- VBRVanguard Small-Cap Value Index FundWeight in the fund0.20%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.19%
- VBVanguard Small-Cap Index FundWeight in the fund0.11%
24 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 153
- Q4 2025: Managers 250
- Q1 2026: Managers 293
- Q2 2026: Managers 310
Institutional investors by quarter
The fund managers holding PRAX, quarter by quarter, from Q4 2020 to Q2 2025, 19 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 310 managers held 33.72M shares, worth $11.3B. During the quarter 59 opened a position, 42 closed one, 119 added and 93 trimmed.
The largest holders, Q2 2026
- Jupiter TopcoIn the quarter
- FMRIn the quarter+7.2%
- BlackRockIn the quarter-1.4%
- Perceptive AdvisorsIn the quarter
- Baker Bros. AdvisorsIn the quarter
- Orbis Allan GrayIn the quarter-38%
- Vanguard Portfolio ManagementIn the quarter+76%
- Vanguard Capital ManagementIn the quarter+1.1%
- State StreetIn the quarter+16%
- Adage Capital Partners GpIn the quarter+24%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Jupiter Topco | 3.42M | $1.1B | |
| FMR | 2.32M | +7.2% | $776M |
| BlackRock | 2.29M | -1.4% | $768M |
| Perceptive Advisors | 2.04M | $682M | |
| Baker Bros. Advisors | 1.75M | $587M | |
| Orbis Allan Gray | 1.53M | -38% | $512M |
| Vanguard Portfolio Management | 1.34M | +76% | $447M |
| Vanguard Capital Management | 1.24M | +1.1% | $414M |
| State Street | 1.03M | +16% | $344M |
| Adage Capital Partners Gp | 1.02M | +24% | $340M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Praxis Precision Medicines's filings show?
Who buys and sells is one part of Praxis Precision Medicines's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have PRAX's insiders bought or sold?
From Jun 12, 2026 to Nov 18, 2026 Praxis Precision Medicines's insiders bought 0 and sold $3.6M of shares on the market. 100% of the sales were under set 10b5-1 plans.
Which well-known managers hold PRAX?
4 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $16M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.